Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Archives of Oral Biology|September 8, 1998
A quantitative histometric murine in vivo model of radiation-induced oral mucositisA M Wardley, D Booth, S A Roberts, et al.
Archives of Disease in Childhood|September 1, 1981
Haemoglobin and prognosis in childhood acute lymphoblastic leukaemiaI M Hann, J H Scarffe, M K Palmer, et al.
Hematological Oncology|January 1, 1989
Cyclosporin associated demyelination following allogeneic bone marrow transplantationM J Lind, L McWilliam, J Jip, et al.
British Journal of Cancer|July 1, 1983
Gynaecomastia complicating the treatment of myelomaD M Large, J M Jones, S M Shalet, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1984
Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemiaE M Rankin, D M Jones, F G Lawston, et al.
Leukemia & Lymphoma|July 1, 1994
Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myelomaB W Baker, M Deane, M H Gilleece, et al.
The Journal of Hospital Infection|November 1, 1996
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unitP R Chadwick, B A Oppenheim, A Fox, et al.
British Journal of Cancer|January 1, 1989
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity studyW P Steward, J H Scarffe, R Austin, et al.
Anti-Cancer Drugs|August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancerA Kamthan, J H Scarffe, J Walling, et al.
Seminars in Oncology|August 1, 1997
Single-agent paclitaxel in advanced non-small cell lung cancer: single-center phase II study using a 3-hour administration scheduleM R Ranson, G Jayson, S Perkins, et al.
Pageof 11